loanDepot, Inc. engages in originating, financing, selling, and servicing residential mortgage loans in the United States. The company offers conventional agency-conforming and prime jumbo, federal assistance residential mortgage, and home equity lines of credit and closed-end second liens. It also provides settlement services, which include captive title and escrow business; real estate services that cover captive real estate referral business; and insurance services, including services to homeowners, as well as other consumer insurance policies. The company was founded in 2010 and is headquartered in Irvine, California.

loanDepot Inc. Class A

Calidi Biotherapeutics ( ($CLDI) ) has issued an update. On March 29, 2026, Calidi Biotherapeutics director Allan J. Camaisa notified the board’s N...

Calidi Biotherapeutics Streamlines Board, Enhances Audit Oversight

An update from Calidi Biotherapeutics ( ($CLDI) ) is now available. On March 6, 2026, Calidi Biotherapeutics, Inc. entered an underwriting agreemen...

Calidi Biotherapeutics Completes Dilutive Public Equity Offering

The latest update is out from loanDepot ( ($LDI) ). loanDepot reported its year-end and fourth-quarter 2025 results on March 10, 2026, highlighting...

Current Quarter	$-0.07	Next Quarter	$NA
Current Year	$0	Next Year	$0.18
QoQ Growth	NaN%	YoY Growth	N/A
3Y EPS CAGR	N/A	Target Price	$2.20
Consensus	Buy	Upside	+57.1%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LDI	$1.40	+0.72%	1.91M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LDI	$1.40	+0.7%	1.91M
3
4
5
6

LDI

LDI

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get loanDepot Inc. Class A Data in Excel

Get loanDepot Inc. Class A Data in Excel